2021 Form 10-K Financial Statement

#000165495422002811 Filed on March 09, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $16.00K $10.00K $8.316M
YoY Change -99.81% -99.91% -74.22%
Cost Of Revenue $7.000M $1.510M $12.97M
YoY Change -46.02% -76.59% -57.17%
Gross Profit -$6.984M -$1.490M -$4.652M
YoY Change 50.13% -133.86% -334.95%
Gross Profit Margin -43650.0% -14900.0% -55.94%
Selling, General & Admin $5.328M $1.510M $5.200M
YoY Change 2.46% 22.76% -10.34%
% of Gross Profit
Research & Development $3.959M $590.0K $2.910M
YoY Change 36.05% -39.18% -25.0%
% of Gross Profit
Depreciation & Amortization $1.789M $1.040M $1.818M
YoY Change -1.6% -5.45% 0.33%
% of Gross Profit
Operating Expenses $9.773M $2.240M -$8.689M
YoY Change -212.48% -4.27% -15.3%
Operating Profit -$16.76M -$3.730M -$13.34M
YoY Change 25.61% -281.07% 61.16%
Interest Expense -$7.086M -$1.490M $710.0K
YoY Change -1098.03% -5066.67% 6.29%
% of Operating Profit
Other Income/Expense, Net $2.000K $0.00 $20.00K
YoY Change -90.0% -100.0% -50.0%
Pretax Income -$22.91M -$5.220M -$14.73M
YoY Change 55.57% -346.23% 74.78%
Income Tax
% Of Pretax Income
Net Earnings -$22.94M -$5.220M -$14.79M
YoY Change 55.14% -346.23% 75.64%
Net Earnings / Revenue -143362.5% -52200.0% -177.79%
Basic Earnings Per Share -$0.12 -$0.09
Diluted Earnings Per Share -$117.2K -$30.72K -$0.09
COMMON SHARES
Basic Shares Outstanding 195.7M shares 169.7M shares 164.3M shares
Diluted Shares Outstanding 195.7B shares 164.3M shares

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.19M $4.300M $4.300M
YoY Change 974.16% -44.87% -44.87%
Cash & Equivalents $37.12M $4.268M $3.400M
Short-Term Investments
Other Short-Term Assets $2.430M $800.0K $800.0K
YoY Change 203.75% -11.11% -11.11%
Inventory $7.814M
Prepaid Expenses $814.0K
Receivables $4.000K $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $48.62M $5.082M $5.100M
YoY Change 853.39% -38.84% -41.38%
LONG-TERM ASSETS
Property, Plant & Equipment $56.33M $21.89M $61.10M
YoY Change -7.81% -7.36% -8.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.89M $15.70M $15.70M
YoY Change 1.2% 5.37% 5.37%
Total Long-Term Assets $72.22M $76.75M $76.70M
YoY Change -5.85% -6.5% -6.12%
TOTAL ASSETS
Total Short-Term Assets $48.62M $5.082M $5.100M
Total Long-Term Assets $72.22M $76.75M $76.70M
Total Assets $120.8M $81.83M $81.80M
YoY Change 47.72% -9.47% -9.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $854.0K $396.0K $400.0K
YoY Change 113.5% -24.28% -20.0%
Accrued Expenses $2.081M $2.000M $2.000M
YoY Change 4.05% 11.11% 11.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.262M $502.0K $500.0K
YoY Change 152.4%
Total Short-Term Liabilities $6.224M $3.584M $3.600M
YoY Change 72.89% 56.99% 56.52%
LONG-TERM LIABILITIES
Long-Term Debt $11.06M $398.0K $12.70M
YoY Change -12.91% 4.1%
Other Long-Term Liabilities $34.17M $31.40M $31.40M
YoY Change 8.82% 5360.87% -0.63%
Total Long-Term Liabilities $45.23M $44.15M $44.10M
YoY Change 2.56% 0.86% 0.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.224M $3.584M $3.600M
Total Long-Term Liabilities $45.23M $44.15M $44.10M
Total Liabilities $51.45M $47.73M $47.70M
YoY Change 7.87% 3.64% 3.47%
SHAREHOLDERS EQUITY
Retained Earnings -$180.2M
YoY Change 8.94%
Common Stock $20.95M
YoY Change -89.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $69.39M $34.10M $34.10M
YoY Change
Total Liabilities & Shareholders Equity $120.8M $81.83M $81.80M
YoY Change 47.72% -9.47% -9.51%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$22.94M -$5.220M -$14.79M
YoY Change 55.14% -346.23% 75.64%
Depreciation, Depletion And Amortization $1.789M $1.040M $1.818M
YoY Change -1.6% -5.45% 0.33%
Cash From Operating Activities -$11.70M -$2.600M -$8.443M
YoY Change 38.55% -158.56% -311.76%
INVESTING ACTIVITIES
Capital Expenditures $1.190M $0.00 $43.00K
YoY Change 2667.44% -100.0% -84.13%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $20.00K
YoY Change -100.0% -100.0% -50.0%
Cash From Investing Activities -$1.190M -$10.00K -$25.00K
YoY Change 4660.0% -87.5% -89.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $54.87M 230.0K $5.327M
YoY Change 930.05% 666.67% -320.03%
NET CHANGE
Cash From Operating Activities -$11.70M -2.600M -$8.443M
Cash From Investing Activities -$1.190M -10.00K -$25.00K
Cash From Financing Activities $54.87M 230.0K $5.327M
Net Change In Cash $42.03M -2.380M -$3.088M
YoY Change -1461.01% -154.21% -322.96%
FREE CASH FLOW
Cash From Operating Activities -$11.70M -$2.600M -$8.443M
Capital Expenditures $1.190M $0.00 $43.00K
Free Cash Flow -$12.89M -$2.600M -$8.486M
YoY Change 51.87% -157.27% -328.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Vancouver, Canada
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
1536000 USD
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
0 USD
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
7923000 USD
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
7814000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7966000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7859000 USD
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
35067000 USD
CY2020Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
39184000 USD
CY2021Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
21260000 USD
CY2020Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
21891000 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
72216000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
76748000 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
203000 USD
CY2021 urg Restricted Stock Unit Redeemed For Cash
RestrictedStockUnitRedeemedForCash
-289000 USD
CY2020 urg Restricted Stock Unit Redeemed For Cash
RestrictedStockUnitRedeemedForCash
-39000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2864000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2320000 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1262000 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
459000 USD
CY2021Q4 urg Current Portion Of Warrant Liability
CurrentPortionOfWarrantLiability
2027000 USD
CY2020Q4 urg Current Portion Of Warrant Liability
CurrentPortionOfWarrantLiability
729000 USD
CY2021Q4 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
71000 USD
CY2020Q4 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
76000 USD
CY2021Q4 us-gaap Assets
Assets
120839000 USD
CY2020Q4 us-gaap Assets
Assets
81830000 USD
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
29915000 USD
CY2020 us-gaap Gross Profit
GrossProfit
-4652000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
-8689000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
-10258000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-13341000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-8278000 USD
CY2020 us-gaap Interest Expense
InterestExpense
710000 USD
CY2019 us-gaap Interest Expense
InterestExpense
668000 USD
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-680000 USD
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
524000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-72000 USD
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-28000 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
18000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
32000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-14785000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-8418000 USD
CY2019 us-gaap Depreciation
Depreciation
1812000 USD
CY2020 us-gaap Depreciation
Depreciation
1818000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
53000 USD
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-16000 USD
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-14732000 USD
CY2019 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-8434000 USD
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164257092 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159903052 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164257092 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159903052 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
51847000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
203000 USD
CY2019 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-70000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
787000 USD
CY2019 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-8434000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
44333000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
99000 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4805000 USD
CY2020 urg Less Share Issue Costs
LessShareIssueCosts
-431000 USD
CY2020 urg Less Amount Assigned To Warrant Liability Amount
LessAmountAssignedToWarrantLiabilityAmount
-860000 USD
CY2020 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-69000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
951000 USD
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-14732000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
34096000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1785000 USD
CY2021 urg Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
11337000 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48672000 USD
CY2021 urg Less Share Issue Costs
LessShareIssueCosts
-2188000 USD
CY2021 urg Less Amount Assigned To Warrant Liability Amount
LessAmountAssignedToWarrantLiabilityAmount
-2604000 USD
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-288000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1079000 USD
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-22503000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
69386000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1080000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
951000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
787000 USD
CY2021 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
7000000 USD
CY2020 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
7802000 USD
CY2019 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
10263000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2045000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2445000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2601000 USD
CY2021 us-gaap Depreciation
Depreciation
1789000 USD
CY2019 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-18000 USD
CY2019 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-524000 USD
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2019 urg Restricted Stock Unit Redeemed For Cash
RestrictedStockUnitRedeemedForCash
-70000 USD
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-16000 USD
CY2021 us-gaap Accretion Expense
AccretionExpense
486000 USD
CY2020 us-gaap Accretion Expense
AccretionExpense
576000 USD
CY2019 us-gaap Accretion Expense
AccretionExpense
577000 USD
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
46000 USD
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
71000 USD
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
108000 USD
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
-903000 USD
CY2020 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2019 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2021 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
5998000 USD
CY2020 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
680000 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
353000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
CY2019 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-28000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7109000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8190000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2997000 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-80000 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
71000 USD
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
544000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
108000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-196000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11698000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8443000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3987000 USD
CY2021 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
0 USD
CY2020 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
0 USD
CY2019 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
9000 USD
CY2021 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 USD
CY2020 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 USD
CY2019 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
19000 USD
CY2021 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 USD
CY2020 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
18000 USD
CY2019 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
18000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1190000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
271000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1190000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-243000 USD
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
48841000 USD
CY2020 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
4805000 USD
CY2019 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
893000 USD
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2020 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2021 urg Share Issue Costs
ShareIssueCosts
-2188000 USD
CY2020 urg Share Issue Costs
ShareIssueCosts
-431000 USD
CY2019 urg Share Issue Costs
ShareIssueCosts
0 USD
CY2019 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2554000 USD
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8507000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
99000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54871000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5327000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2421000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
45000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
53000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
62000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42028000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3088000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1385000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12127000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15215000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13830000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54155000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12127000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15215000 USD
CY2021 us-gaap Nature Of Operations
NatureOfOperations
<table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1. </strong></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Nature of Operations</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Ur-Energy Inc. (the “Company”) was incorporated on March 22, 2004 under the laws of the Province of Ontario. The Company continued under the Canada Business Corporations Act on August 8, 2006. The Company is an exploration stage issuer, as defined by U.S. Securities and Exchange Commission (“SEC”). The Company is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located primarily in Wyoming. The Company commenced uranium production at its Lost Creek Project in Wyoming in 2013.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the nature of the uranium recovery methods used by the Company on the Lost Creek Property, and the definition of “mineral reserves” under Subpart 1300 to Regulation S-K (“S-K 1300”), the Company has not determined whether the properties contain mineral reserves. This was true while the Company reported its mineral resources pursuant to National Instrument 43-101 (“NI 43-101”), which uses the Canadian Institute of Mining, Metallurgy and Petroleum (“CIM”) Definition Standards. The Company’s report <em>The Lost Creek ISR Uranium Property, Sweetwater County, Wyoming,</em> March 7, 2022 (the “Lost Creek Report”) outlines the potential viability of the Lost Creek Property. The recoverability of amounts recorded for mineral properties is dependent upon the discovery of economic resources, the ability of the Company to obtain the necessary financing to develop the properties and upon attaining future profitable production from the properties or sufficient proceeds from disposition of the properties.</p></td></tr></tbody></table>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The most significant estimates management makes in the preparation of these consolidated financial statements relate to the fair value of stock-based compensation and warrant liabilities using the factors associated with the Black-Scholes calculations, estimation of the amount of recoverable uranium included in the in-process inventory, estimation of factors surrounding asset retirement obligations such as interest rates, discount rates and inflation rates, total cost and the time until the asset retirement commences and the offset of future income taxes through deferred tax assets. Actual results could differ from those estimates.</p>
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46189000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4268000 USD
CY2021 urg Assets Held For Sale
AssetsHeldForSale
<table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>4.</strong></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Assets Held for Sale</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">A non-core, unpermitted, non-operating property held by Pathfinder Mines Corporation is presently considered to be an asset held for sale. The Company has a plan to sell the asset and is considering an offer consisting of cash and mineral properties. The asset’s mineral property cost as shown in the table below has been reclassified as assets held for sale as of December 31, 2021. There were no liabilities associated with the asset held for sale as of December 31, 2021.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">   </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px;background-color:#ffffff"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net assets held for sale </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Assets held for sale </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Mineral properties </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,536</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;"/><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021 urg Mineral Properties
MineralProperties
1536000 USD
CY2020 urg Mineral Properties
MineralProperties
0 USD
CY2021 urg Net Assets Held For Sale
NetAssetsHeldForSale
1536000 USD
CY2021Q4 urg Cash Pledged For Reclamation
CashPledgedForReclamation
7966000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7966000 USD
CY2018Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
45805000 USD
CY2019 us-gaap Acquisition Costs
AcquisitionCosts
8000 USD
CY2019 urg Change In Estimated Reclamation Costs
ChangeInEstimatedReclamationCosts
11000 USD
CY2019 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
11000 USD
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-2601000 USD
CY2019Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
43212000 USD
CY2020 urg Change In Estimated Reclamation Costs
ChangeInEstimatedReclamationCosts
-1583000 USD
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-2445000 USD
CY2020Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
39184000 USD
CY2021 urg Reclassify Assets Held For Sale
ReclassifyAssetsHeldForSale
-1536000 USD
CY2021 urg Change In Estimated Reclamation Costs
ChangeInEstimatedReclamationCosts
-536000 USD
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-2045000 USD
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
35067000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
903000 USD
CY2021Q1 us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
0.90
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
502000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
398000 USD
CY2021 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
13710000 USD
CY2022 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
1842000 USD
CY2023 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
5934000 USD
CY2024 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
5934000 USD
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
29965000 USD
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
29915000 USD
CY2019 urg Beginning Balance Warrant Liabilities
BeginningBalanceWarrantLiabilities
1050000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 USD
CY2019 urg Mark To Market Revaluation Loss Gain
MarkToMarketRevaluationLossGain
-524000 USD
CY2019 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
49000 USD
CY2019 urg Ending Balance Warrant Liabilities
EndingBalanceWarrantLiabilities
575000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
860000 USD
CY2020 urg Mark To Market Revaluation Loss Gain
MarkToMarketRevaluationLossGain
680000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
29000 USD
CY2021 urg Beginning Balance Warrant Liabilities
BeginningBalanceWarrantLiabilities
2144000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2604000 USD
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4446000 USD
CY2021 urg Mark To Market Revaluation Loss Gain
MarkToMarketRevaluationLossGain
5998000 USD
CY2021 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
37000 USD
CY2021 urg Ending Balance Warrant Liabilities
EndingBalanceWarrantLiabilities
6263000 USD
CY2021 urg Current Portion Of Warrant Liability1
CurrentPortionOfWarrantLiability1
2027 USD
CY2021 urg Warrant Liability
WarrantLiability
4236 USD
CY2021 urg Totalwarrant Liability
TotalwarrantLiability
6263 USD
CY2020Q4 urg Number Of Options Exercisable
NumberOfOptionsExercisable
200 USD
CY2020Q3 urg Direct Offering Closed
DirectOfferingClosed
46800 USD
CY2020Q3 us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
0.52
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
46800 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
40000 USD
CY2020Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
430000 USD
CY2020Q3 urg Common Stock No Par Values
CommonStockNoParValues
0.75
CY2020 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
259640 shares
CY2020Q4 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
100000 USD
CY2021Q1 urg Shares Issued Upon Public Offering
SharesIssuedUponPublicOffering
14722200 shares
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
15200000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
7361100 shares
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2208330 shares
CY2021Q4 us-gaap Investment Sold Not Yet Purchased Balance Shares
InvestmentSoldNotYetPurchasedBalanceShares
1104165 shares
CY2021Q1 urg Class Of Warrant Or Right Exercise Price Of Warrants
ClassOfWarrantOrRightExercisePriceOfWarrants
1.35
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1300000 USD
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
13900000 USD
CY2021 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
19151457 shares
CY2021Q4 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
33400000 USD
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
32600000 USD
CY2021Q4 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
14050920 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
395851 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.71
CY2021 urg Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding
10064024 shares
CY2021 urg Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding
0.68
CY2021Q4 urg Number Of Options Exercisable
NumberOfOptionsExercisable
1800000 USD
CY2019Q4 urg Number Of Options Exercisable
NumberOfOptionsExercisable
200000 USD
CY2021 urg Share Based Compensation Expenses
ShareBasedCompensationExpenses
700000 USD
CY2020 urg Share Based Compensation Expenses
ShareBasedCompensationExpenses
600000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6006883 shares
CY2019 urg Share Based Compensation Expenses
ShareBasedCompensationExpenses
500000 USD
CY2021 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1200000 USD
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10064024 shares
CY2021 urg Schedule Of Stock Option Fair Value Assumptionstabletextblock
ScheduleOfStockOptionFairValueAssumptionstabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Stock Options Fair Value Assumptions </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2019 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2018 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2017 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Expected forfeiture rate </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.8% - 6.0%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.3% - 6.0%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Expected life (years) </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.7 -3.8 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Expected volatility </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">69.5</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63.2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">53.8% - 55.0% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">56.0% - 57.5% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Risk free rate </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.9% - 2.1%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.0% - 1.6%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Expected dividend rate </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Black-Scholes value (CAD$) </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.74</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.30</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$0.33 - $0.39</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$0.32 - $0.44</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2019 urg Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate
SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate
0.062 pure
CY2017 urg Expected Life Years
ExpectedLifeYears
P3Y8M12D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.586 pure
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016 pure
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2019 urg Black Scholes Value Cad
BlackScholesValueCad
0.35
CY2019 urg Number Of Rsus Unvested Granted
NumberOfRsusUnvestedGranted
713106 shares
CY2019 urg Granted Weighted Average Grant Date Fair Value
GrantedWeightedAverageGrantDateFairValue
0.61
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
542674 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.68
CY2018Q3 urg Common Stock No Par Values
CommonStockNoParValues
1.00
CY2020Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
9000000 shares
CY2020 urg Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate
RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate
0.042 pure
CY2021 urg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding
1011660 shares
CY2021 urg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding
0.69
CY2020 urg Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad
RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad
0.63
CY2020Q3 urg Common Shares Purchase
CommonSharesPurchase
4500000 shares
CY2020Q3 urg Class Of Warrant Or Right Exercise Price Of Warrants
ClassOfWarrantOrRightExercisePriceOfWarrants
0.75
CY2021Q1 urg Common Stock No Par Values
CommonStockNoParValues
1.35
CY2019 urg Class Of Warrant Or Right Outstanding Beginning
ClassOfWarrantOrRightOutstandingBeginning
13062878 shares
CY2019 urg Class Of Warrants Or Right Shares Issued On Exercise Beginning
ClassOfWarrantsOrRightSharesIssuedOnExerciseBeginning
6531439 shares
CY2019 urg Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Beginning
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Beginning
1.00
CY2021 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
6900000 shares
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5200000 USD
CY2020 urg Revenue From Contract With Customer Excluding Assessed Tax And Disposal Fee Income
RevenueFromContractWithCustomerExcludingAssessedTaxAndDisposalFeeIncome
8316000 USD
CY2020 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
CY2019 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5801000 USD
CY2019 urg Revenue From Contract With Customer Excluding Assessed Tax And Disposal Fee Income
RevenueFromContractWithCustomerExcludingAssessedTaxAndDisposalFeeIncome
32252000 USD
CY2021 urg Disposal Fee Income
DisposalFeeIncome
16000 USD
CY2021 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
CY2020 urg Disposal Fee Income
DisposalFeeIncome
16000 USD
CY2020 urg Disposal Fee Income Concentration Risk Percentage
DisposalFeeIncomeConcentrationRiskPercentage
0.002 pure
CY2019 urg Disposal Fee Income
DisposalFeeIncome
3000 USD
CY2019 urg Disposal Fee Income Concentration Risk Percentage
DisposalFeeIncomeConcentrationRiskPercentage
0.000 pure
CY2021 urg Revenue From Contract With Customer Excluding Assessed Tax And Disposal Fee Income
RevenueFromContractWithCustomerExcludingAssessedTaxAndDisposalFeeIncome
16000 USD
CY2021 urg Disposal Fee Income Concentration Risk Percentage
DisposalFeeIncomeConcentrationRiskPercentage
1.000 pure
CY2021 urg Cost Of Product Sales
CostOfProductSales
0 USD
CY2020 urg Cost Of Product Sales
CostOfProductSales
5166000 USD
CY2019 urg Cost Of Product Sales
CostOfProductSales
20011000 USD
CY2021 urg Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
7000000 USD
CY2021 us-gaap Accretion Expense
AccretionExpense
486000 USD
CY2020 urg Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
7802000 USD
CY2020 us-gaap Accretion Expense
AccretionExpense
576000 USD
CY2019 us-gaap Accretion Expense
AccretionExpense
577000 USD
CY2020 us-gaap Development Costs
DevelopmentCosts
1097000 USD
CY2019 us-gaap Development Costs
DevelopmentCosts
1404000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5328000 USD
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9773000 USD
CY2020 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8689000 USD
CY2019 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10258000 USD
CY2019 urg Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
10264000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7000000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12968000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30275000 USD
CY2021 us-gaap Exploration Expense
ExplorationExpense
2037000 USD
CY2020 us-gaap Exploration Expense
ExplorationExpense
1816000 USD
CY2019 us-gaap Exploration Expense
ExplorationExpense
2476000 USD
CY2021 us-gaap Development Costs
DevelopmentCosts
1922000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46189000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4268000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7403000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7966000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7859000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7812000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54155000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12127000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15215000 USD
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
800000 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
800000 USD
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
900000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12841000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11184000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38800000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35366000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
51641000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
46550000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
0 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
0 USD
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
16000 USD
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
2 USD
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
18000 USD
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
500000 USD
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2900000 USD
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1300000 USD
CY2021Q4 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
46200000 USD

Files In Submission

Name View Source Status
0001654954-22-002811-index-headers.html Edgar Link pending
0001654954-22-002811-index.html Edgar Link pending
0001654954-22-002811.txt Edgar Link pending
0001654954-22-002811-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
urg-20211231.xsd Edgar Link pending
urg-20211231_cal.xml Edgar Link unprocessable
urg-20211231_def.xml Edgar Link unprocessable
urg-20211231_lab.xml Edgar Link unprocessable
urg-20211231_pre.xml Edgar Link unprocessable
urg_10k.htm Edgar Link pending
urg_10kimg10.jpg Edgar Link pending
urg_10kimg11.jpg Edgar Link pending
urg_10kimg15.jpg Edgar Link pending
urg_10kimg16.jpg Edgar Link pending
urg_10kimg19.jpg Edgar Link pending
urg_10kimg20.jpg Edgar Link pending
urg_10kimg21.jpg Edgar Link pending
urg_10kimg5.jpg Edgar Link pending
urg_10kimg9.jpg Edgar Link pending
urg_10k_htm.xml Edgar Link completed
urg_ex211.htm Edgar Link pending
urg_ex211img1.jpg Edgar Link pending
urg_ex231.htm Edgar Link pending
urg_ex231img1.jpg Edgar Link pending
urg_ex232.htm Edgar Link pending
urg_ex311.htm Edgar Link pending
urg_ex312.htm Edgar Link pending
urg_ex321.htm Edgar Link pending
urg_ex322.htm Edgar Link pending
urg_ex42.htm Edgar Link pending
urg_ex961.htm Edgar Link pending
urg_ex961img127.jpg Edgar Link pending
urg_ex961img128.jpg Edgar Link pending
urg_ex961img129.jpg Edgar Link pending
urg_ex961img133.jpg Edgar Link pending
urg_ex961img134.jpg Edgar Link pending
urg_ex961img138.jpg Edgar Link pending
urg_ex961img140.jpg Edgar Link pending
urg_ex961img143.jpg Edgar Link pending
urg_ex961img144.jpg Edgar Link pending
urg_ex961img145.jpg Edgar Link pending
urg_ex961img146.jpg Edgar Link pending
urg_ex961img147.jpg Edgar Link pending
urg_ex961img148.jpg Edgar Link pending
urg_ex961img150.jpg Edgar Link pending
urg_ex961img152.jpg Edgar Link pending
urg_ex961img156.jpg Edgar Link pending
urg_ex961img157.jpg Edgar Link pending
urg_ex961img158.jpg Edgar Link pending
urg_ex961img159.jpg Edgar Link pending
urg_ex961img160.jpg Edgar Link pending
urg_ex961img161.jpg Edgar Link pending
urg_ex961img216.jpg Edgar Link pending
urg_ex961img217.jpg Edgar Link pending
urg_ex961img218.jpg Edgar Link pending
urg_ex961img219.jpg Edgar Link pending
urg_ex961img220.jpg Edgar Link pending
urg_ex961img222.jpg Edgar Link pending
urg_ex961img224.jpg Edgar Link pending
urg_ex961img225.jpg Edgar Link pending
urg_ex961img66.jpg Edgar Link pending
urg_ex962.htm Edgar Link pending
urg_ex962img44.jpg Edgar Link pending
urg_ex962img45.jpg Edgar Link pending
urg_ex962img47.jpg Edgar Link pending
urg_ex962img98.jpg Edgar Link pending
urg_ex962img99.jpg Edgar Link pending
urg_ex991img17.jpg Edgar Link pending
urg_ex991img19.jpg Edgar Link pending
urg_ex991img20.jpg Edgar Link pending
urg_ex991img21.jpg Edgar Link pending
urg_ex991img22.jpg Edgar Link pending
urg_ex991img23.jpg Edgar Link pending
urg_ex991img24.jpg Edgar Link pending
urg_ex991img25.jpg Edgar Link pending
urg_ex991img26.jpg Edgar Link pending
urg_ex991img28.jpg Edgar Link pending
urg_ex991img29.jpg Edgar Link pending
urg_ex991img30.jpg Edgar Link pending
urg_ex991img31.jpg Edgar Link pending
urg_ex991img35.jpg Edgar Link pending
urg_ex991img36.jpg Edgar Link pending
urg_ex991img37.jpg Edgar Link pending
urg_ex991img38.jpg Edgar Link pending
urg_ex991img40.jpg Edgar Link pending
urg_ex991img41.jpg Edgar Link pending
urg_ex991img43.jpg Edgar Link pending